Filing Details

Accession Number:
0001209191-20-055424
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-20 19:59:46
Reporting Period:
2020-10-20
Accepted Time:
2020-10-20 19:59:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819790 Tarsus Pharmaceuticals Inc. TARS Biological Products, (No Disgnostic Substances) (2836) 814717861
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827839 Viii Partnership Limited Horowitz 5030 Campus Drive, Suite A
Newport Beach CA 92660
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-20 1,434,790 $0.00 1,434,790 No 4 C Direct
Common Stock Acquisiton 2020-10-20 245,966 $0.00 1,680,756 No 4 C Direct
Common Stock Acquisiton 2020-10-20 71,427 $0.00 1,752,183 No 4 C Direct
Common Stock Acquisiton 2020-10-20 168,750 $16.00 1,920,933 No 4 P Direct
Common Stock Acquisiton 2020-10-20 43,151 $0.00 43,151 No 4 C Indirect By the Adam S. Horowitz Revocable Trust
Common Stock Acquisiton 2020-10-20 7,396 $0.00 50,547 No 4 C Indirect By the Adam S. Horowitz Revocable Trust
Common Stock Acquisiton 2020-10-20 15,625 $16.00 66,172 No 4 P Indirect By the Adam S. Horowitz Revocable Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
No 4 C Indirect By the Adam S. Horowitz Revocable Trust
No 4 C Indirect By the Adam S. Horowitz Revocable Trust
No 4 P Indirect By the Adam S. Horowitz Revocable Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2020-10-20 1,434,790 $0.00 1,434,790 $0.00
Common Stock Series B Preferred Stock Disposition 2020-10-20 245,966 $0.00 245,966 $0.00
Common Stock Series C Preferred Stock Disposition 2020-10-20 71,427 $0.00 71,427 $0.00
Common Stock Series A Preferred Stock Disposition 2020-10-20 43,151 $0.00 43,151 $0.00
Common Stock Series B Preferred Stock Disposition 2020-10-20 7,396 $0.00 7,396 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis. The shares of Preferred Stock had no expiration date.
  2. The shares are held by Adam S. Horowitz Revocable Trust, of which Adam S. Horowitz is Trustee. Adam S. Horowitz is affiliated with Horowitz Limited Partnership VIII.